Key result
Longer diabetes duration is linked to cardiac autonomic neuropathy, affecting ~70% of T2D patients.
Why the study?
The study was conducted to investigate the prevalence and risk factors for cardiac autonomic neuropathy in patients with type 2 diabetes mellitus.
Population
100 patients with type 2 diabetes mellitus
Comparison
Patients with CAN vs without CAN
Design
Cross-sectional cohort study
Authors
Loading...
May warrant CAN vigilance in long-duration T2DM; cross-sectional data leave causal links and screening impact open.
Cross-Sectional (n=100)
No
Odds Ratio: 6.7
p-value: p=<0.0001
Cardiac autonomic neuropathy is highly prevalent (70%) among patients with type 2 diabetes, strongly associated with longer diabetes duration, older age, and reduced eGFR.
Baro et al. (2019) conducted a cross-sectional in Type 2 diabetes mellitus (n=100). Duration of diabetes was evaluated on Cardiac autonomic neuropathy (CAN) (OR 6.7, p=<0.0001). Longer duration of diabetes (OR 6.7, P<0.0001), older age, and lower eGFR were significant risk factors for cardiac autonomic neuropathy, which had a 70% prevalence in type 2 diabetes patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: